DAVA Pharmaceuticals, Inc. FDA Inspection Record
DAVA Pharmaceuticals, Inc. is an FDA-inspected facility (FEI 3006193930) located in Fort Lee, NJ, US. RegDataLab tracks 2 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Jul 6, 2012: Voluntary Action Indicated (VAI)
- Inspections on record
- 2 (2 VAI)
- Last OAI inspection
- None on record
- Warning letters
- 1 listed by FDA for this FEI, latest Oct 13, 2009
- Recalls as the recalling firm
- 2, latest Aug 3, 2011
- Import refusals
- 1
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jul 6, 2012 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Training--operations, GMPs, written procedures (21 CFR 211.25(a)) Failure to develop written procedures (21 CFR 314.80(b)) Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) and 2 more |
| Mar 3, 2011 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Written record of complaint to include findings, follow-up (21 CFR 211.198(b)(2)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Aug 3, 2011 | Class III | D-884-2012 | Albuterol Sulfate Extended-Release Tablets, 4 mg, 100-count tablets per bottle, Rx only… and 1 more product Failed USP Dissolution Test Requirements: These lots are being recalled due to a failure on stability test for dissolution at 19-months… |
| May 2, 2008 | Class III | D-233-2008 | Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100 and 1000 tablet bottles, Rx only… Exceeded Impurity Specification; 24 month stability |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
3 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jul 6, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 3, 2011 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Oct 13, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing DAVA Pharmaceuticals, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check DAVA Pharmaceuticals, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- DAVA Pharmaceuticals, Inc.
- Location
- Fort Lee, NJ (US)
- Source
- inspections